Status:

TERMINATED

INFUSE ® Bone Graft/CORNERSTONE-SR® Allograft Ring/ATLANTIS® Anterior Cervical Plate System Pivotal Trial

Lead Sponsor:

Medtronic Spinal and Biologics

Conditions:

Degenerative Cervical Disc Disease

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The purpose of this trial is to evaluate the implant (INFUSE™ BONE GRAFT/CORNERSTONE-SR™ Allograft Ring/ATLANTIS™ Anterior Cervical Plate system) as a method of facilitating spinal fusion in patients ...

Eligibility Criteria

Inclusion

  • Cervical disc disease defined as: intractable radiculopathy and/or myelopathy with at least one of the following items producing symptomatic nerve root and/or spinal cord compression which is documented by diagnostic imaging procedures:
  • herniated disc;
  • osteophyte formation;
  • decreased disc height;
  • thickening of ligamentous tissue;
  • disc degeneration; and/or
  • facet joint degeneration.
  • Has preoperative Neck Disability Index score \> 30;
  • Has single cervical disc disease level requiring fusion from C2 to C7;
  • No previous surgical intervention at the involved fusion level;
  • Unresponsive to nonoperative treatment for approximately six weeks or has the presence of progressive symptoms or signs of nerve root or spinal cord compression in face of continued nonoperative management;
  • Is at least 18 years of age, inclusive at time of surgery;
  • If of child-bearing potential, patient is non-pregnant, non-nursing, and agrees to use adequate contraception for 1 year following surgery;
  • Is willing and able to comply with study plan and sign the consent form.

Exclusion

  • Has cervical spinal condition requiring surgical treatment other than symptomatic cervical disc disease at the involved level.
  • Has a condition which requires postoperative medications that interfere with fusion, such as steroids or prolonged non-steroidal anti-inflammatory drugs excluding routine perioperative anti-inflammatory drugs. This does not include low dose aspirin for prophylactic anticoagulation.
  • Has been previously diagnosed with osteopenia, or osteomalacia.
  • Has any of the following that may be associated with a diagnosis of osteoporosis (if "Yes" to any of the below risk factors, a DEXA Scan will be required to determine eligibility).
  • Postmenopausal Non-Black female over 60 years of age and weighs less than 140 pounds.
  • Postmenopausal female that has sustained a non-traumatic hip, spine, or wrist fracture.
  • Male over the age of 70.
  • Male over the age of 60 that has sustained a non-traumatic hip or spine fracture.
  • If the level of BMD is a T score of -3.5 or a T score of -2.5 with vertebral crush fracture, the patient is excluded from the study.
  • Has presence of active malignancy or prior history of malignancy, except for basal cell carcinoma of the skin.
  • Has overt or active bacterial infection, either local or systemic.
  • Has a documented titanium alloy allergy or intolerance.
  • Is mentally incompetent. If questionable, obtain psychiatric consult.
  • Is a prisoner.
  • Is an alcohol and/or drug abuser as defined by currently undergoing treatment for alcohol and/or drug usage.
  • Has received drugs which may interfere with bone metabolism within two weeks prior to the planned date of spinal fusion surgery (e.g., steroids or methotrexate), excluding routine perioperative anti-inflammatory drugs.
  • Has a history of autoimmune disease (Systemic Lupus Erythematosus or Dermatomyositis).
  • Has a history of exposure to injectable collagen implants.
  • Has a history of hypersensitivity to protein pharmaceuticals (monoclonal antibodies or gamma globulins) or collagen.
  • Has received treatment with an investigational therapy within 28 days prior to implantation surgery or such treatment is planned during the 16 weeks following rhBMP-2/ACS implantation.
  • Has received any previous exposure to any/all BMP's of either human or animal extraction.

Key Trial Info

Start Date :

April 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2005

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT01491477

Start Date

April 1 2002

End Date

April 1 2005

Last Update

August 2 2013

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.